Last update 21 Nov 2024

PWT-33597

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
PI3Kα x mTOR
Mechanism
PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced cancerSolid tumor
Originator Organization
Pathway Therapeutics, Inc.Pathway Therapeutics, Inc.
Active Organization-
Inactive Organization
Pathway Therapeutics, Inc.Pathway Therapeutics, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC27H34F2N8O7S2
InChIKeyXSLUGEGXPCDRTN-UHFFFAOYSA-N
CAS Registry1246203-36-0
View All Structures (2)

Related

1
Clinical Trials associated with PWT-33597
NCT01407380 / CompletedPhase 1
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
100 Clinical Results associated with PWT-33597
Login to view more data
100 Translational Medicine associated with PWT-33597
Login to view more data
100 Patents (Medical) associated with PWT-33597
Login to view more data
100 Deals associated with PWT-33597
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
US
Pathway Therapeutics, Inc.Pathway Therapeutics, Inc.
01 Jun 2011
Solid tumorPhase 1
US
Pathway Therapeutics, Inc.Pathway Therapeutics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free